Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

University of Oxford-led research finds low-dose rapamycin functions as a genomic protector in aging human immune cells, ...

BACKGROUND: Whereas antiphospholipid syndrome (APS) is best known for increasing the risk of macrovascular thrombosis, APS vasculopathy is characterized by the abnormal proliferation of endothelial ...

Explore in vitro strategies for developing anti-TSLP biotherapeutics, supporting early-stage screening and accelerated ...

Fragment 176-191 peptide sequence, corresponding to amino acids 176 to 191 of hGH, is theorized to support lipid metabolism ...

From axolotls to zebrafish, stem cells possess remarkable regenerative abilities, enabling them to restore lost limbs and repair damaged organs. These extraordinary capabilities, however, are not ...

Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...